ONCY insider transactions
Oncolytics Biotech Inc. (ONCY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for ONCY
- Director Parsons James T. bought $10,300 worth of shares (10,000 units at $1.03), increasing direct ownership by 31% to 41,849 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Chief Executive Officer Kelly Jared bought $4,848 worth of shares (5,050 units at $0.96), increasing direct ownership by 5% to 114,050 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Director Pisano Wayne bought $25,338 worth of shares (30,000 units at $0.84), increasing direct ownership by 6% to 492,414 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Chief Executive Officer Kelly Jared bought $29,521 worth of shares (35,100 units at $0.84), increasing direct ownership by 47% to 109,000 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- VP, Product Development Hagerman Allison bought $8,298 worth of shares (10,000 units at $0.83), increasing direct ownership by 10% to 115,059 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Chief Financial Officer Look Kirk bought $10,104 worth of shares (12,000 units at $0.84), increasing direct ownership by 4% to 287,515 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Director Andrews Patricia S bought $30,292 worth of shares (35,400 units at $0.86), increasing direct ownership by 83% to 78,128 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Chief Medical Officer Heineman Thomas Charles bought $10,033 worth of shares (12,132 units at $0.83), increasing direct ownership by 4% to 282,818 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Chief Business Officer Aromando Andrew bought $25,418 worth of shares (29,600 units at $0.86), increasing direct ownership by 116% to 55,100 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Director Brown Deborah Margaret bought $21,240 worth of shares (25,000 units at $0.85), increasing direct ownership by 29% to 109,851 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Director Seizinger Bernd R. bought $83,454 worth of shares (100,000 units at $0.83), increasing direct ownership by 21% to 566,991 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- Director Seizinger Bernd R. bought $103,770 worth of shares (100,000 units at $1.04), increasing direct ownership by 27% to 466,991 units (SEC Form 4)4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Kelly Jared claimed ownership of 73,900 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Andrews Patricia S claimed ownership of 42,728 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Look Kirk claimed ownership of 275,515 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Hagerman Allison claimed ownership of 105,059 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Parsons James T. claimed ownership of 31,849 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Pisano Wayne claimed ownership of 462,414 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Seizinger Bernd R. claimed ownership of 366,991 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Holtham Angela claimed ownership of 183,639 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Heineman Thomas Charles claimed ownership of 270,686 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Brown Deborah Margaret claimed ownership of 84,851 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Rigby Jonathan claimed ownership of 42,728 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)
- New insider Aromando Andrew claimed ownership of 25,500 shares (SEC Form 3)3 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)